Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$5.7MFederal grants as PI4 awards
3Patents grantedLatest Sep 5, 2023
98Papers9,597 citations
Federal awards and patents by year
AwardsPatents
4 awards · $5.7M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 15, 2023 | NIH | SBIR Phase I Developing a novel treatment of cocaine use disorder using an IND dual inhibitor of Cav3 channel and soluble epoxide hydrolase | $320K | AFASCI, INC. |
| Sep 30, 2018 | NIH | SBIR Phase II IND-enabling studies on novel Cav3 T-channel modulators for treatment of neuropathic pain | $3.0M | AFASCI, INC. |
| Mar 1, 2017 | NIH | SBIR Phase II Development of patented tricyclic pyrones molecules for the treatment of Alzheimer's Disease | $2.2M | AFASCI, INC. |
| Apr 1, 2016 | NIH | SBIR Phase I Developing a novel CGRP antagonist for treatment of dental neuroinflammatory pain | $222K | AFASCI, INC. |
4 patents as inventor
- US 10287337AFASCI, INC.May 14, 2019
- US 10562857AFASCI, INC.Feb 18, 2020
- US 11744825AFASCI, INC.Sep 5, 2023
- US AFASCI, INC.—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#212
Awards as PI#566
Patents#63
Companies
- AFASCI, INC.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.